Lyfegen Acquires CHF 5 Million Series A Funding for Global Expansion of Rebate Management Technology Lyfegen has successfully raised CHF 5 million in Series A funding, enhancing its drug rebate management platform and enabling global expansion.

Lyfegen Acquires CHF 5 Million Series A Funding for Global Expansion of Rebate Management Technology #Switzerland #Basel #Lyfegen #TX_Ventures #aMoon